VIM and malignant colon neoplasm: We found that CD11b+ macrophages were accumulated in tumor regions of WT and Vim−/− colon cancer samples (Figure 3H) similar to after DSS treatment in Figure 2C, suggesting that loss of vimentin not only may increase susceptibility to inflammation but also may greatly accelerate inflammation-associated colon cancer.